Letrofil 2.5 mg Tablet
  1. Home
  2. Pharma Products
  3. Fourrts India Laboratories Pvt Ltd
  4. Letrofil 2.5 mg Tablet

Letrofil 2.5 mg Tablet

Letrofil 2.5 mg Tablet contains letrozole and is an oral anticancer medicine used primarily for hormone-sensitive breast cancer. It belongs to the aromatase inhibitor group and works by reducing estrogen production in the body. Letrofil 2.5 mg Tablet is manufactured and marketed by Fourrts India Laboratories Pvt Ltd.

BUY NOW

Category

Letrozole blocks the aromatase enzyme, which reduces estrogen levels that can support the growth of certain breast cancer cells. Letrofil 2.5 mg Tablet is mainly used for breast cancer in postmenopausal women according to the prescribed treatment plan. It can be taken orally with or without food and should be used for the duration recommended by the treating physician. Medical monitoring may include bone health, cholesterol levels, and other treatment-related effects during long-term therapy.

Technical Specification

Specification Details
Active Ingredient Letrozole
Strength 2.5 mg
Dosage Form Tablet
Route of Administration Oral
Therapeutic Class Aromatase Inhibitor
Manufacturer/Marketer Fourrts India Laboratories Pvt Ltd

Product Also Known As

Letrofil 2.5 mg, Letrofil 2.5 mg Tablet, Letrofil 2.5mg Tablet, Letrozole 2.5 mg Tablet, Letrozole 2.5mg, Letrozole Tablet, Aromatase Inhibitor Tablet